Dr. Jeremy Shawn Katcher, MD

Dr. Katcher practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Katcher's NPI, 1124235239, was assigned on May 17, 2007. Dr. Katcher graduated from University of Missouri, Columbia School of Medicine in 2005. Dr. Katcher holds Missouri license 2010013490.

Dr. Katcher's primary practice is Washington University School of Medicine, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 747-5192.

Dr. Katcher's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Katcher is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Katcher to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katcher practices, 6 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Katcher's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Katcher is board certified in internal medicine by the American Board of Internal Medicine. Dr. Katcher is licensed in Missouri.

CMS data shows 12,131 Medicare services from Dr. Katcher across 14 procedure codes in 2024, for 272 Medicare patients. Medicare paid $263,618 for them. Every service was in an office.

CMS counts 272 Medicare patients who saw Dr. Katcher in 2024. The largest group is 65 to 74, with 156 patients. 69% of them have high cholesterol, and 65% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katcher's median patient age at 50, with 69% women.

In 2024, Dr. Katcher wrote 736 Medicare Part D claims for 147 patients. 64% of them were for generic drugs. CMS names the drug for 562 of them, across 18 drugs with 11 or more claims each, at $377,156 in total drug cost. In 2023, CMS named 342 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Katcher for performance year 2024, reported as part of a group. Dr. Katcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katcher as offering telehealth.

CMS Open Payments shows 639 general payments to Dr. Katcher from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Sanofi and Genzyme US Companies paid the most, $4,148. It also lists 16 research payments totaling $2,328 in 2024.

Dr. Katcher graduated from University of Missouri, Columbia School of Medicine in 2005.